Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma
Conditions
Renal Cell Carcinoma (Kidney Cancer) · Metastatic Renal Cell Carcinoma · Locally Advanced
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Centre Hospitalier d'Annecy, Annecy, France
Institut Sainte Catherine, Avignon, France
Contact: Principal Investigator (BILLEMONT)Centre Hospitalier de Bayeux, Bayeux, France
Contact: Principal Investigator (BRACHET)CH Boulogne sur Mer, Boulogne-sur-Mer, France
Centre François Baclesse, Caen, France
Contact: Principal Investigator (Romain LEVARD)Polyclinique du Parc Elsan, Caen, France
Contact: Principal Investigator (VILLEMIN)Institut Andrée Dutreix, Coudekerque-Branche, France
Ghpso Creil, Creil, France
Contact: Principal Investigator (CAROLA)Institut de cancérologie de Bourgogne, Dijon, France
Centre Hospitalier de Lorient, Lorient, France
Contact: Principal Investigator (Marie L'HUISSIER)Centre Léon Bérard, Lyon, France
Chu Montpellier, Montpellier, France
GHR Mulhouse Sud Alsace, Mulhouse, France
Contact: Principal Investigator (TABET)Centre Antoine Lacassagne, Nice, France
Chu Poitiers, Poitiers, France
CHU, Saint-Etienne, France
Contact: Principal Investigator (CORNILLON)Hôpital FOCH, Suresnes, France
Centre Hospitalier de Tours, Tours, France
Contact: Principal Investigator (CANCEL)Centre d'oncologie St Yves, Vannes, France